Perdaman Appoints Electric Hydrogen as Preferred Electrolyser Vendor for Project Helios
Karratha, Western Australia | 17th August – Perdaman is proud to announce the appointment of Electric Hydrogen as its preferred
Delivering Quality Pharmaceuticals to the World
Sunrise International Labs, a wholly owned subsidiary of Perdaman Pharmaceuticals, is a leading pharmaceutical manufacturing and exporting company based in Hyderabad, India. Established in 1986, SIL has built a strong reputation for excellence in drug delivery systems and therapeutic solutions. As a WHO/cGMP certified facility, it upholds the highest quality standards, ensuring safe and effective pharmaceutical formulations for global markets. The company operates on a 100,000-square-foot facility, featuring state-of-the-art research and development labs, quality control centers, and an advanced water treatment plant. With approvals from regulatory agencies across Ethiopia, Ivory Coast, Senegal, Uganda, Sri Lanka, and Cambodia, it continues to expand its international footprint.
At Sunrise International Labs, innovation and quality go hand in hand. The facility houses cutting-edge laboratories specialising in microbiology, chemical analysis, and formulation research, supporting the development of tablets, capsules, liquid orals, sachets, and effervescent tablets. With a mission to provide affordable and high-quality medicines to every corner of the globe, SIL remains dedicated to improving global healthcare. Now strengthened by Perdaman Pharmaceuticals, SIL is poised for growth, expanding its capabilities to serve broader markets while maintaining its commitment to excellence.
Our Portfolio
Sunrise International Labs boasts world-class manufacturing facilities, cutting-edge research and development capabilities, and a diverse pharmaceutical product portfolio. Our WHO/cGMP-certified facility ensures the highest quality standards, driving innovation in drug formulation while producing a wide range of tablets, capsules, liquid orals, sachets, and effervescent tablets for global markets.
Manufacturing Facilities
Our WHO/cGMP-certified facility ensures high-quality pharmaceutical production with advanced technology, strict compliance, and efficient operations.
Research and Development
Cutting-edge R&D drives innovation, enhancing drug formulations and therapeutic solutions with expertise from highly skilled professionals.
Products
We offer a diverse range of pharmaceutical products, including tablets, capsules, liquid orals, sachets, and effervescent tablets for global markets.
Perdaman Makes History Once Again with Landmark Refinery Project in Western Australia
Karratha, Western Australia | 28th July – Perdaman is proud to announce plans for a Made in WA Fuel Refinery,
Perdaman Breaks Ground on 30MW Renewable Energy Project Development in Karratha
Karratha, Western Australia | 4th March – Perdaman is pleased to announce the official groundbreaking of Project Helios – Phase
